Knacke’s money maps: Health is wealth
In his new monthly column, Ernst Knacke, head of research at Shard Capital, looks at the life sciences and biotech space
M&A
-
-
Hargreaves Lansdown accepts £5.4bn private equity takeover
Deal expected to close in first quarter of 2025
-
BNP Paribas to buy AXA IM for €5.4bn
Deal is expected to complete in the first half of 2025
-
Can we expect broader consolidation among investment trusts?
The investment trust sector is increasingly willing to take difficult choices to deliver shareholder value
-
Witan Alliance merger ‘best-fit outcome’, but questions raised over WTAN’s trust holdings
Some 8% of Witan’s portfolio is invested in other trusts
-
Alliance Trust joins forces with Witan in UK’s largest-ever investment trust merger
The merger is the result of Witan CEO Andrew Bell’s impending retirement
-
Hipgnosis and Bidco boards move one step closer towards revised acquisition deal
Bidco initially revised its offer for SONG on 3 June
-
Hargreaves Lansdown receives fresh £5.4bn approach from private equity consortium
HL board would be willing to recommend the offer to shareholders should interest be firmed up
-
Tritax EuroBox: No formal offer has been received from Brookfield
Brookfield announced it is in the ‘early stages’ of assessing a cash offer
-
FE FundInfo: UK small caps top May performance charts
‘The UK market finally appears to be garnering attention’
-
Blackstone increases Hipgnosis offer to £1.27bn
While the bid will now be executed via a scheme of arrangement
-
Cannacord Genuity strikes deal to acquire £900m Cantab Asset Management
Expected to complete in the third quarter of this year